Home1AI • ASX
Algorae Pharmaceuticals Ltd
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 208.32K | -66.81% |
Net income | -326.36K | 55.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.41M | -33.55% |
Total assets | 2.54M | -32.52% |
Total liabilities | 145.73K | 3.97% |
Total equity | 2.39M | — |
Shares outstanding | 1.69B | — |
Price to book | ∞ | — |
Return on assets | -20.53% | — |
Return on capital | -21.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -326.36K | 55.02% |
Cash from operations | -350.28K | 30.54% |
Cash from investing | 100.00K | 120.46% |
Cash from financing | — | — |
Net change in cash | -250.68K | 65.80% |
Free cash flow | -123.30K | -503.45% |
Previous close
$0.0050
Day range
$0.0050 - $0.0050
Year range
$0.0050 - $0.013
Market cap
4.22M AUD
Avg Volume
831.84K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
1987
Website
